Organs-on-Chips Market

Organs-on-Chips Market Analysis by Liver, Heart, and Lungs for Drug Discovery and Toxicology Research from 2023 to 2033

Analysis of Organs-on-Chips Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Organs-on-Chips Market Outlook (2023 to 2033)

The global organs-on-chips market size is valued at US$ 103 million in 2023 and is predicted to surge and attain an impressive valuation of US$ 1.45 billion by 2033-end. As per this elaborate Fact.MR research study, worldwide shipments of organs-on-chips are projected to rise at an astronomical 30.3% CAGR over the next ten years.

Organs-on-chips or organoid chips are masses of cells or tissues that emulate the function of an organ or different types of organs. Organs-on-chips are anticipated to find extensive use in the drug development process as they allow researchers to study the exact impact of drugs on organs and get a detailed analysis of effects at the cellular and molecular level, which is expected to drive sales of organs-on-chips through 2033.

Rising concerns regarding the testing of drugs on animals, growing demand for personalized medicine, increasing investments in healthcare research, and supportive government funding are other factors that are expected to positively influence the organs-on-chips market potential across the forecast period. Shortage of organ donors and lack of availability of functional lab-engineered organs are also slated to drive shipments of organs-on-chips over the next five years.

  • In March 2023, MIMETAS, a leading company using organ-on-chip technology for disease modelling based in the Netherlands, announced that it had launched its Adult Stem Cell (ASC)-derived tubular organoids in an assay-ready format as part of its OrganoReady® product line.

The advent of 3D bioprinting in the medical technology sector is projected to allow organ-on-chip companies to reduce their manufacturing and deployment costs, which could further boost organ-on-chip demand in the long run. Innovations in biomaterials and advancements in 3D printing technology are also slated to aid organ-on-chip vendors in scaling their business to the next level.

  • In April 2023, BIO INX, a Belgian start-up developing inks for a wide scope of applications such as bioprinting and 3D printing, revealed its new resin that could be used to 3D print organs-on-chips. Hydrotech INX N200 is a biocompatible hydrogel resin created for two-photon polymerization (2PP).

Contrastingly, organs-on-chips technology is still in its nascent stage, which is why it requires heavy investments to develop, commercialize, and launch. This also results in expensive end products that are so high in cost that the majority of the general population around the world cannot afford them. The aforementioned aspects act as major restraints for organs-on-chips market revenue generation throughout the forecast period.

Report Attributes Details

Organs-on-Chips Market Size (2023)

US$ 103 Million

Projected Market Value (2033F)

US$ 1.45 Billion

Global Market Growth Rate (2023 to 2033)

30.3% CAGR

Leading Regional Market

North America

Key Market Segment

Lungs-on-Chips

Key Companies Profiled

  • CN Bio Innovations
  • Kirkstall
  • Visikol
  • SynVivo
  • Tara Biosystems Inc.
  • MIMETAS
  • HemoShear Therapeutics LLC
  • Organovo Holdings Inc.
  • AxoSim
  • Nortis
  • Emulate Inc.
  • TissUse GmbH
  • InSphero
  • BioIVT
  • Hesperos Inc.

Don't Need a Global Report?

save 40%! on Country & Region specific reports

What are Start-ups Doing to Bridge the Gap in the Organs-on-Chips Industry?

“Capital Raise – Essential for New Organ-on-Chip Companies Trying to Innovate”

Organs-on-chips is a technology that is still in its nascent and developmental phases, which is why it requires a substantial amount of research and development that incurs high costs for companies developing them. This is why incoming organs-on-chips providers are focusing on raising new funding to finance their R&D efforts and improve their business potential in the future.

  • In June 2023, Dynamic42 GmbH, an innovative organ-on-chip specialist based in Germany, announced that it had closed a mid-seven-figure Series A financing round to expand its business on an international level. Lead investor bm-t beteiligungsmanagement thüringen GmbH has played a crucial role in funding this start-up right from 2018.
  • In August 2022, Nortis, a company focusing on developing organ-on-chip technology using microfluidics, announced that it had raised US$ 6 million in cash. This was revealed in an SEC filing and the company is focusing on the development of human cells that can mimic the function of organs such as kidney, liver, lungs, heart, etc.
  • Emulate Inc., a biotechnology start-up focused on organ-on-a-chip technology, announced that it had raised US$ 82 million in a Series E round in September 2021. The company had plans to utilize this funding to create a blueprint for developing novel organ systems that could be used by drug makers in labs to eliminate the need for animal testing.
  • Finnadvance, a Finnish organ-on-chip start-up, announced that it has raised around US$ 1.19 million in a seed funding round in April 2022, which was led by Athensmed and was backed by Voima Ventures and Icebreaker who are the existing investors of the company. Finnadvance was expected to use this funding to broaden its research scope and reach out to new markets such as the United States.

Start-ups can benefit by learning more about aspects such as local supply, pricing trends, product standards, safety regulations, and new developments that have been discussed extensively in this organs-on-chips industry study by skilled analysts at Fact.MR, a market research and competitive intelligence provider.

Organs-on-Chips Market Size, Share, Trends, Growth, Demand and Sales Forecast Report by Fact.MR

Country-wise Insights

Where in Asia Will Organ-on-Chip Companies Get Sizeable Returns on Their Investments?

“China and India to Offer Lucrative Moneymaking Opportunities”

Organs-on-chips market revenue share in Asian countries such as India and China is projected to increase at a rapid pace across the forecast period and beyond. This can be ascribed to a rising focus on healthcare innovation and growing investments in medical R&D activities in the aforementioned Asian countries.

Surging incidence of chronic diseases, growing patient pool, and rising mortality rates due to unavailability of organ donors are other influential prospects that could potentially bolster organ-on-chip sales in Japan, China, India along with other Asian countries over the next ten years.

Why Should Organ-on-Chip Manufacturers Invest in the United States?

“High Healthcare Expenditure and Rapid Adoption of Novel Technologies”

The U.S. organs-on-chips market is expected to be a highly lucrative market over the years to come and the growth can be attributed to the increasing geriatric population, high research activity in the healthcare industry, supportive government initiatives, presence of key pharmaceutical and biotechnology companies, and rising acceptance of organs-on-chips.

The country is home to some of the major biotechnology and pharmaceutical companies, and a high focus on R&D in these organizations is expected to favour the overall market potential through 2033. The presence of an advanced healthcare infrastructure that is quick to adopt novel healthcare technologies also makes the United States a highly remunerative space for organ-on-chip companies going forward

Which European Countries are Key Markets for Suppliers of Organs-on-Chips?

“Germany, United Kingdom – Opportune Markets in Europe”

Sizeable amounts of investments have been made in research and development of organ-on-chip technology in European countries such as Germany and the United Kingdom. Germany is home to some of the most prominent start-ups making waves in the organs-on-chips space and this is why the country has become a hotbed for innovations in the marketplace thereby attracting investors.

Increasing focus on healthcare and rising demand for drug discovery and screening are anticipated to be prime drivers for organ-on-chip demand in the United Kingdom. Supportive initiatives by the government to promote R&D in the organs-on-chips space are also opening up new frontiers of opportunities for established as well as new organ-on-chip companies going forward.

  • In 2020, a new research center was opened at Queen Mary University of London to facilitate medical research and drug development using organ-on-chip technology. The ‘Queen Mary-Emulate Organs-on-Chips Centre’ was established through a partnership between Emulate Inc., a United States-based company developing organs-on-chips, and Queen Mary University.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Category-wise Insights

Which Type Organs-on-Chip is Exhibiting High Demand?

“Lungs-on-Chips to Account for Substantial Sales Growth”

The global organs-on-chips market, based on organ, is segmented into liver, heart, lungs, and other organs.

The lungs segment is anticipated to lead the overall organs-on-chips market revenue generation capacity owing to lower lung transplantations and increasing investments in the development of lungs-on-chips. The rising use of lab-engineered lungs in the drug screening process owing to the high prevalence of respiratory disorders is also expected to drive growth in this segment over the years to come.

Demand for heart-on-chip is also anticipated to exhibit a lucrative growth outlook owing to the increasing incidence of cardiovascular disorders across the world which is expected to rise as the senescent population increases through 2033.

Competitive Landscape

Leading organ-on-chip manufacturers are focusing on mergers, collaborations, and acquisitions to expand their business scope and bolster their presence in the global competitive landscape.

  • In April 2022, Valo Health, a technology company focused on revolutionizing the drug discovery process, announced that it was acquiring TARA Biosystems to bolster its cardiovascular drug discovery business. TARA’s 3D heart tissue modelling platform and its heart tissue chips will be key to Valo’s advancements in cardiovascular drug discovery and development.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Key Segments of Organs-on-Chips Industry Research

  • By Organ :

    • Liver
    • Heart
    • Lungs
    • Other Organs
  • By Application :

    • Drug Discovery
    • Toxicology Research
    • Other Applications
  • By End User :

    • Pharmaceutical & Biotechnology Companies
    • Academic & Research Institutions
    • Other End Users
  • By Region :

    • North America
    • Latin America
    • Europe
    • APAC
    • MEA

Table of Content

1. Global Market - Executive Summary

    1.1. Global Market Overview

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Fact.MR Analysis and Recommendations

2. Global Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Introduction and Definition

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Crisis and Impact on Organs-on-Chips

        3.1.2. COVID-19 Crisis and Impact on Aprotic Solvent Prices

        3.1.3. COVID-19 Impact Benchmark with Previous Crisis

            3.1.3.1. Change in Demand

            3.1.3.2. Before and After COVID-19 Crisis (Projected)

            3.1.3.3. Before and After Sub-prime Crisis – 2008 (Actual)

            3.1.3.4. Change in Demand post Recovery Period (After Each Crisis)

        3.1.4. Impact on Market and Value (US$ Mn)

            3.1.4.1. Likely Loss of Value in 2022

            3.1.4.2. Mid-term and Long Term Forecast

            3.1.4.3. Quarter by Quarter Demand and Recovery Assessment

        3.1.5. Anticipated Demand and Value Recovery Curve

            3.1.5.1. Likelihood of U-Shape Recovery

            3.1.5.2. Likelihood of L-Shape Recovery

        3.1.6. Recovery Period Assessment by Key Countries

        3.1.7. Recovery Assessment by Key Market Segments

        3.1.8. Action Points and Recommendations for Suppliers

        3.1.9. Impact on Trade Balance

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Source Development Trends

4. Market Background and foundation Data Points

    4.1. Need of the Hour for Industries

    4.2. Industry Wise Industry 4.0

    4.3. Strategic Priorities

    4.4. Life Cycle Stage

    4.5. Importance of Technology

    4.6. Use Cases of Organs-on-Chips

    4.7. Forecast Factors: Relevance and Impact

    4.8. Investment Feasibility Matrix

    4.9. PESTLE Analysis

    4.10. Porter’s Five Forces Analysis

    4.11. Market Dynamics

        4.11.1. Drivers

        4.11.2. Restraints

        4.11.3. Opportunity Analysis

        4.11.4. Trend

5. Global Market Demand (US$ Mn) Analysis 2018-2022 and Forecast, 2023-2033

    5.1. Historical Market Value (US$ Mn) Analysis, 2018-2022

    5.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033

        5.2.1. Y-o-Y Growth Trend Analysis

        5.2.2. Absolute $ Opportunity Analysis

6. Global Market Analysis 2018-2022 and Forecast 2023-2033, By Organ

    6.1. Introduction / Key Findings

    6.2. Historical Market Value (US$ Mn) Analysis By Organ, 2018-2022

    6.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Organ, 2023-2033

        6.3.1. Liver

        6.3.2. Heart

        6.3.3. Lungs

        6.3.4. Other Organs

    6.4. Market Attractiveness Analysis By Organ

7. Global Market Analysis 2018-2022 and Forecast 2023-2033, by Application

    7.1. Introduction / Key Findings

    7.2. Historical Market Value (US$ Mn) Analysis By Application , 2018-2022

    7.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Application, 2023-2033

        7.3.1. Drug Discovery

        7.3.2. Toxicology Research

        7.3.3. Other Applications

    7.4. Market Attractiveness Analysis By Application

8. Global Market Analysis 2018-2022 and Forecast 2023-2033, by End User

    8.1. Introduction / Key Findings

    8.2. Historical Market Value (US$ Mn) Analysis By End User, 2018-2022

    8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By End User, 2023-2033

        8.3.1. Pharmaceutical & Biotechnology Companies

        8.3.2. Academic & Research Institutions

        8.3.3. Other End Users

    8.4. Market Attractiveness Analysis By End User

9. Global Market Analysis 2018-2022 and Forecast 2023-2033, by Region

    9.1. Introduction / Key Findings

    9.2. Historical Market Value (US$ Mn) Analysis By Region, 2018-2022

    9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023-2033

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. East Asia

        9.3.5. South Asia & Oceania

        9.3.6. Middle East and Africa (MEA)

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2018-2022 and Forecast 2023-2033

    10.1. Introduction / Key Findings

    10.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    10.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033

        10.3.1. By Country

            10.3.1.1. U.S.

            10.3.1.2. Canada

        10.3.2. By Organ

        10.3.3. By Application

    10.4. Market Attractiveness Analysis

        10.4.1. By Country

        10.4.2. By Organ

        10.4.3. By Application

11. Latin America Market Analysis 2018-2022 and Forecast 2023-2033

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023-2033

        11.3.1. By Country

            11.3.1.1. Brazil

            11.3.1.2. Mexico

            11.3.1.3. Rest of Latin America

        11.3.2. By Organ

        11.3.3. By Application

        11.3.4. By End User

    11.4. Market Attractiveness Analysis

        11.4.1. By Country

        11.4.2. By Organ

        11.4.3. By Application

        11.4.4. By End User

12. Europe Market Analysis 2018-2022 and Forecast 2023-2033

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023-2033

        12.3.1. By Country

            12.3.1.1. Germany

            12.3.1.2. France

            12.3.1.3. Italy

            12.3.1.4. Spain

            12.3.1.5. UK

            12.3.1.6. BENELUX

            12.3.1.7. Russia

            12.3.1.8. Rest of Europe

        12.3.2. By Organ

        12.3.3. By Application

        12.3.4. By End User

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Organ

        12.4.3. By Application

        12.4.4. By End User

13. East Asia Market Analysis 2018-2022 and Forecast 2023-2033

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023-2033

        13.3.1. By Country

            13.3.1.1. China

            13.3.1.2. Japan

            13.3.1.3. South Korea

        13.3.2. By Organ

        13.3.3. By Application

        13.3.4. By End User

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Organ

        13.4.3. By Application

        13.4.4. By End User

14. South Asia & Oceania Market Analysis 2018-2022 and Forecast 2023-2033

    14.1. Introduction / Key Findings

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023-2033

        14.3.1. By Country

            14.3.1.1. India

            14.3.1.2. Thailand

            14.3.1.3. Malaysia

            14.3.1.4. Singapore

            14.3.1.5. Vietnam

            14.3.1.6. ANZ

            14.3.1.7. Rest of South Asia & Oceania

        14.3.2. By Organ

        14.3.3. By Application

        14.3.4. By End User

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Organ

        14.4.3. By Application

        14.4.4. By End User

15. Middle East and Africa Market Analysis 2018-2022 and Forecast 2023-2033

    15.1. Introduction / Key Findings

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023-2033

        15.3.1. By Country

            15.3.1.1. GCC Countries

            15.3.1.2. South Africa

            15.3.1.3. Israel

            15.3.1.4. Rest of Middle East and Africa (MEA)

        15.3.2. By Organ

        15.3.3. By Application

        15.3.4. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Organ

        15.4.3. By Application

        15.4.4. By End User

16. Market Structure Analysis

    16.1. Market Analysis by Tier of Companies

    16.2. Market Concentration

    16.3. Market Share Analysis of Top Players

    16.4. Market Presence Analysis

17. Competition Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Competition Deep Dive

        17.3.1. CN Bio Innovations

            17.3.1.1. Company Overview

            17.3.1.2. Source overview

            17.3.1.3. SWOT Analysis

            17.3.1.4. Key Developments

        17.3.2. InSphero

            17.3.2.1. Company Overview

            17.3.2.2. Source overview

            17.3.2.3. SWOT Analysis

            17.3.2.4. Key Developments

        17.3.3. BioIVT

            17.3.3.1. Company Overview

            17.3.3.2. Source overview

            17.3.3.3. SWOT Analysis

            17.3.3.4. Key Developments

        17.3.4. Kirkstall

            17.3.4.1. Company Overview

            17.3.4.2. Source overview

            17.3.4.3. SWOT Analysis

            17.3.4.4. Key Developments

        17.3.5. HemoShear Therapeutics LLC

            17.3.5.1. Company Overview

            17.3.5.2. Source overview

            17.3.5.3. SWOT Analysis

            17.3.5.4. Key Developments

        17.3.6. Visikol

            17.3.6.1. Company Overview

            17.3.6.2. Source overview

            17.3.6.3. SWOT Analysis

            17.3.6.4. Key Developments

        17.3.7. SynVivo

            17.3.7.1. Company Overview

            17.3.7.2. Source overview

            17.3.7.3. SWOT Analysis

            17.3.7.4. Key Developments

        17.3.8. AxoSim

            17.3.8.1. Company Overview

            17.3.8.2. Source overview

            17.3.8.3. SWOT Analysis

            17.3.8.4. Key Developments

        17.3.9. Nortis

            17.3.9.1. Company Overview

            17.3.9.2. Source overview

            17.3.9.3. SWOT Analysis

            17.3.9.4. Key Developments

        17.3.10. Emulate Inc.

            17.3.10.1. Company Overview

            17.3.10.2. Source overview

            17.3.10.3. SWOT Analysis

            17.3.10.4. Key Developments

        17.3.11. Tara Biosystems Inc.

            17.3.11.1. Company Overview

            17.3.11.2. Source overview

            17.3.11.3. SWOT Analysis

            17.3.11.4. Key Developments

        17.3.12. MIMETAS

            17.3.12.1. Company Overview

            17.3.12.2. Source overview

            17.3.12.3. SWOT Analysis

            17.3.12.4. Key Developments

        17.3.13. Organovo Holdings Inc.

            17.3.13.1. Company Overview

            17.3.13.2. Source overview

            17.3.13.3. SWOT Analysis

            17.3.13.4. Key Developments

        17.3.14. TissUse GmbH

            17.3.14.1. Company Overview

            17.3.14.2. Source overview

            17.3.14.3. SWOT Analysis

            17.3.14.4. Key Developments

        17.3.15. Hesperos Inc.

            17.3.15.1. Company Overview

            17.3.15.2. Source overview

            17.3.15.3. SWOT Analysis

            17.3.15.4. Key Developments

18. Assumptions And Acronyms Used

19. Research Methodology

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

Table 01: Global Market Value (US$ Mn) Analysis, by Organ, 2018-2022

Table 02: Global Market Value (US$ Mn) Analysis, by Organ, 2023-2033

Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Organ, 2023-2033

Table 04: Global Market Value (US$ Mn) Analysis, by Application, 2018-2022

Table 05: Global Market Value (US$ Mn) Analysis, by Application, 2023-2033

Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Application, 2023-2033

Table 07: Global Market Value (US$ Mn) Analysis, by End User, 2018-2022

Table 08: Global Market Value (US$ Mn) Analysis, by End User, 2023-2033

Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2023-2033

Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2018-2022

Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2023-2033

Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2023-2033

Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2018-2022

Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2023-2033

Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023-2033

Table 16: North America Market Value (US$ Mn) Analysis, by Organ, 2018-2022

Table 17: North America Market Value (US$ Mn) Analysis, by Organ, 2023-2033

Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Organ, 2023-2033

Table 19: North America Market Value (US$ Mn) Analysis, by Application, 2018-2022

Table 20: North America Market Value (US$ Mn) Analysis, by Application, 2023-2033

Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Application, 2023-2033

Table 22: North America Market Value (US$ Mn) Analysis, by End User, 2018-2022

Table 23: North America Market Value (US$ Mn) Analysis, by End User, 2023-2033

Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2023-2033

Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2018-2022

Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2023-2033

Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023-2033

Table 28: Latin America Market Value (US$ Mn) Analysis, by Organ, 2018-2022

Table 29: Latin America Market Value (US$ Mn) Analysis, by Organ, 2023-2033

Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Organ, 2023-2033

Table 31: Latin America Market Value (US$ Mn) Analysis, by Application, 2018-2022

Table 32: Latin America Market Value (US$ Mn) Analysis, by Application, 2023-2033

Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Application, 2023-2033

Table 34: Latin America Market Value (US$ Mn) Analysis, by End User, 2018-2022

Table 35: Latin America Market Value (US$ Mn) Analysis, by End User, 2023-2033

Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2023-2033

Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2018-2022

Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2023-2033

Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2023-2033

Table 40: Europe Market Value (US$ Mn) Analysis, by Organ, 2018-2022

Table 41: Europe Market Value (US$ Mn) Analysis, by Organ, 2023-2033

Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Organ, 2023-2033

Table 43: Europe Market Value (US$ Mn) Analysis, by Application, 2018-2022

Table 44: Europe Market Value (US$ Mn) Analysis, by Application, 2023-2033

Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Application, 2023-2033

Table 46: Europe Market Value (US$ Mn) Analysis, by End User, 2018-2022

Table 47: Europe Market Value (US$ Mn) Analysis, by End User, 2023-2033

Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2023-2033

Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2018-2022

Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2023-2033

Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2023-2033

Table 52: East Asia Market Value (US$ Mn) Analysis, by Organ, 2018-2022

Table 53: East Asia Market Value (US$ Mn) Analysis, by Organ, 2023-2033

Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Organ, 2023-2033

Table 55: East Asia Market Value (US$ Mn) Analysis, by Application, 2018-2022

Table 56: East Asia Market Value (US$ Mn) Analysis, by Application, 2023-2033

Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Application, 2023-2033

Table 58: East Asia Market Value (US$ Mn) Analysis, by End User, 2018-2022

Table 59: East Asia Market Value (US$ Mn) Analysis, by End User, 2023-2033

Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2023-2033

Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2018-2022

Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2023-2033

Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2023-2033

Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Organ, 2018-2022

Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Organ, 2023-2033

Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Organ, 2023-2033

Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Application, 2018-2022

Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Application, 2023-2033

Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Application, 2023-2033

Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2018-2022

Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2023-2033

Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by End User, 2023-2033

Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2018-2022

Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2023-2033

Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2023-2033

Table 76: MEA Market Value (US$ Mn) Analysis, by Organ, 2018-2022

Table 77: MEA Market Value (US$ Mn) Analysis, by Organ, 2023-2033

Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Organ, 2023-2033

Table 79: MEA Market Value (US$ Mn) Analysis, by Application, 2018-2022

Table 80: MEA Market Value (US$ Mn) Analysis, by Application, 2023-2033

Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Application, 2023-2033

Table 82: MEA Market Value (US$ Mn) Analysis, by End User, 2018-2022

Table 83: MEA Market Value (US$ Mn) Analysis, by End User, 2023-2033

Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2023-2033

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2018-2022

Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2023-2033

Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2018-2033

Figure 04: Global Market Incremental $ Opportunity, 2023-2033

Figure 05: Global Market Share and BPS Analysis by Organ, 2023 & 2033

Figure 06: Global Market Y-o-Y Growth Projections by Organ, 2023-2033

Figure 07: Global Market Attractiveness Analysis by Organ, 2023-2033

Figure 08: Global Market Share and BPS Analysis by Application, 2023 & 2033

Figure 09: Global Market Y-o-Y Growth Projections by Application, 2023-2033

Figure 10: Global Market Attractiveness Analysis by Application, 2023-2033

Figure 11: Global Market Share and BPS Analysis by End User, 2023 & 2033

Figure 12: Global Market Y-o-Y Growth Projections by End User, 2023-2033

Figure 13: Global Market Attractiveness Analysis by End User, 2023-2033

Figure 14: Global Market Share and BPS Analysis by Region, 2023 & 2033

Figure 15: Global Market Y-o-Y Growth Projections by Region, 2023-2033

Figure 16: Global Market Attractiveness Analysis by Region, 2023-2033

Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2018-2022

Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2023-2033

Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2023-2033

Figure 20: North America Market Incremental $ Opportunity, 2023-2033

Figure 21: North America Market Share Analysis by Country, 2023 & 2033

Figure 22: North America Market Y-o-Y Growth Projection by Country, 2023-2033

Figure 23: North America Market Attractiveness Analysis by Country, 2023-2033

Figure 24: North America Market Share and BPS Analysis by Organ, 2023 & 2033

Figure 25: North America Market Y-o-Y Growth Projections by Organ, 2023-2033

Figure 26: North America Market Attractiveness Analysis by Organ, 2023-2033

Figure 27: North America Market Share and BPS Analysis by Application, 2023 & 2033

Figure 28: North America Market Y-o-Y Growth Projections by Application, 2023-2033

Figure 29: North America Market Attractiveness Analysis by Application, 2023-2033

Figure 30: North America Market Share and BPS Analysis by End User, 2023 & 2033

Figure 31: North America Market Y-o-Y Growth Projections by End User, 2023-2033

Figure 32: North America Market Attractiveness Analysis by End User, 2023-2033

Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2018-2022

Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2023-2033

Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2018-2033

Figure 36: Latin America Market Incremental $ Opportunity, 2023-2033

Figure 37: Latin America Market Share Analysis by Country, 2023 & 2033

Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2023-2033

Figure 39: Latin America Market Attractiveness Analysis by Country, 2023-2033

Figure 40: Latin America Market Share and BPS Analysis by Organ, 2023 & 2033

Figure 41: Latin America Market Y-o-Y Growth Projections by Organ, 2023-2033

Figure 42: Latin America Market Attractiveness Analysis by Organ, 2023-2033

Figure 43: Latin America Market Share and BPS Analysis by Application, 2023 & 2033

Figure 44: Latin America Market Y-o-Y Growth Projections by Application, 2023-2033

Figure 45: Latin America Market Attractiveness Analysis by Application, 2023-2033

Figure 46: Latin America Market Share and BPS Analysis by End User, 2023 & 2033

Figure 47: Latin America Market Y-o-Y Growth Projections by End User, 2023-2033

Figure 48: Latin America Market Attractiveness Analysis by End User, 2023-2033

Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2018-2022

Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2023-2033

Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2018-2033

Figure 52: Europe Market Incremental $ Opportunity, 2023-2033

Figure 53: Europe Market Share Analysis by Country, 2023 & 2033

Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2023-2033

Figure 55: Europe Market Attractiveness Analysis by Country, 2023-2033

Figure 56: Europe Market Share and BPS Analysis by Organ, 2023 & 2033

Figure 57: Europe Market Y-o-Y Growth Projections by Organ, 2023-2033

Figure 58: Europe Market Attractiveness Analysis by Organ, 2023-2033

Figure 59: Europe Market Share and BPS Analysis by Application, 2023 & 2033

Figure 60: Europe Market Y-o-Y Growth Projections by Application, 2023-2033

Figure 61: Europe Market Attractiveness Analysis by Application, 2023-2033

Figure 62: Europe Market Share and BPS Analysis by End User, 2023 & 2033

Figure 63: Europe Market Y-o-Y Growth Projections by End User, 2023-2033

Figure 64: Europe Market Attractiveness Analysis by End User, 2023-2033

Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2018-2022

Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2023-2033

Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2018-2033

Figure 68: East Asia Market Incremental $ Opportunity, 2023-2033

Figure 69: East Asia Market Share Analysis by Country, 2023 & 2033

Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2023-2033

Figure 71: East Asia Market Attractiveness Analysis by Country, 2023-2033

Figure 72: East Asia Market Share and BPS Analysis by Organ, 2023 & 2033

Figure 73: East Asia Market Y-o-Y Growth Projections by Organ, 2023-2033

Figure 74: East Asia Market Attractiveness Analysis by Organ, 2023-2033

Figure 75: East Asia Market Share and BPS Analysis by Application, 2023 & 2033

Figure 76: East Asia Market Y-o-Y Growth Projections by Application, 2023-2033

Figure 77: East Asia Market Attractiveness Analysis by Application, 2023-2033

Figure 78: East Asia Market Share and BPS Analysis by End User, 2023 & 2033

Figure 79: East Asia Market Y-o-Y Growth Projections by End User, 2023-2033

Figure 80: East Asia Market Attractiveness Analysis by End User, 2023-2033

Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2018-2022

Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2023-2033

Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2018-2033

Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2023-2033

Figure 85: South Asia & Oceania Market Share Analysis by Country, 2023 & 2033

Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2023-2033

Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2023-2033

Figure 88: South Asia & Oceania Market Share and BPS Analysis by Organ, 2023 & 2033

Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Organ, 2023-2033

Figure 90: South Asia & Oceania Market Attractiveness Analysis by Organ, 2023-2033

Figure 91: South Asia & Oceania Market Share and BPS Analysis by Application, 2023 & 2033

Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Application, 2023-2033

Figure 93: South Asia & Oceania Market Attractiveness Analysis by Application, 2023-2033

Figure 94: South Asia & Oceania Market Share and BPS Analysis by End User, 2023 & 2033

Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by End User, 2023-2033

Figure 96: South Asia & Oceania Market Attractiveness Analysis by End User, 2023-2033

Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2018-2022

Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2023-2033

Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2018-2033

Figure 100: MEA Market Incremental $ Opportunity, 2023-2033

Figure 101: MEA Market Share Analysis by Country, 2023 & 2033

Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2023-2033

Figure 103: MEA Market Attractiveness Analysis by Country, 2023-2033

Figure 104: MEA Market Share and BPS Analysis by Organ, 2023 & 2033

Figure 105: MEA Market Y-o-Y Growth Projections by Organ, 2023-2033

Figure 106: MEA Market Attractiveness Analysis by Organ, 2023-2033

Figure 107: MEA Market Share and BPS Analysis by Application, 2023 & 2033

Figure 108: MEA Market Y-o-Y Growth Projections by Application, 2023-2033

Figure 109: MEA Market Attractiveness Analysis by Application, 2023-2033

Figure 110: MEA Market Share and BPS Analysis by End User, 2023 & 2033

Figure 111: MEA Market Y-o-Y Growth Projections by End User, 2023-2033

Figure 112: MEA Market Attractiveness Analysis by End User, 2023-2033

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

- FAQs -

How big is the organs-on-chips market in 2023?

The global organs-on-chips market accounts for a valuation of US$ 103 million in 2023.

What is the projected organs-on-chips market size for 2033?

Organ-on-chip sales are forecasted to reach US$ 1.45 billion by 2033-end.

At what CAGR is the global market projected to expand?

Worldwide sales of organs-on-chips are predicted to skyrocket at 30.3% CAGR over the next ten years.

Which organs-on-chips will witness higher demand through 2033?

Lungs-on-chips are estimated to account for high sales across the forecast period.

Who are the major organ-on-chip manufacturing companies in the industry?

SynVivo, Tara Biosystems Inc., MIMETAS, HemoShear Therapeutics LLC, Organovo Holdings Inc., AxoSim, and Nortis are some of the leading companies in the market.

Organs-on-Chips Market

Schedule a Call